Skip to main content
. 2022 Feb 10;13:813218. doi: 10.3389/fimmu.2022.813218

Figure 6.

Figure 6

The change of invasion and proliferation of HTR8/SVneo cells after inhibiting CD39 and CD73. Representative photos (A) and data (B) for the matrigel transwell assay of normal dNK cells from healthy donors co-cultured with the HTR-8/SVneo cells (dNK: HTR-8/SVneo cells = 2:1) in the absence or presence of the CD39 inhibitor ARL67156 and/or the CD73 inhibitor APCP. n = 3 for each group (mean ± SEM, **P < 0.01 compared with the untreated group, one-way ANOVA and post hoc tests). (C) The OD values of the HTR-8/SVneo cells in the CCK-8 assay, showing their proliferation capacities (mean ± SEM, *P < 0.05, **P < 0.01 compared with the untreated group, one-way ANOVA and post hoc tests).